VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
TECH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
TECHBio-Techne Corporation
$72.78$11.4B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksTECHQuarterly Financials

Bio-Techne Corporation (TECH) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Bio-Techne Corporation (TECH) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

TECH Income Statement

Quarterly statement

TECH Income Statement

Bio-Techne Corporation (TECH) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ1'27Q4'26Q3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22
Sales/Revenue299.71M321.19M311.42M295.88M286.56M316.96M316.18M297.03M289.46M306.1M303.43M272.6M276.94M301.32M294.15M271.58M269.65M288.23M290.38M269.28M
Revenue Growth %4.59%1.33%-1.51%-0.39%-1%3.55%4.2%8.96%4.52%1.59%3.16%0.37%2.7%4.54%1.3%0.86%4.63%11.27%19.23%20.08%
Cost of Goods Sold103.09M109.8M103.13M104.6M98.44M118.15M101.63M103.14M106.44M102.75M98.83M96.01M91.74M96.62M91.98M88.22M90.06M87.88M88.92M85.58M
COGS % of Revenue34.4%34.18%33.12%35.35%34.35%37.28%32.14%34.73%36.77%33.57%32.57%35.22%33.13%32.07%31.27%32.48%33.4%30.49%30.62%31.78%
Gross Profit196.62M211.39M208.29M191.28M188.11M198.81M214.56M193.89M183.02M203.35M204.6M176.59M185.19M204.7M202.16M183.36M179.59M200.35M201.46M183.69M
Gross Margin %65.6%65.82%66.88%64.65%65.65%62.72%67.86%65.27%63.23%66.43%67.43%64.78%66.87%67.93%68.73%67.52%66.6%69.51%69.38%68.22%
Gross Profit Growth %4.52%6.33%-2.92%-1.35%2.78%-2.23%4.87%9.8%-1.17%-0.66%1.21%-3.69%3.12%2.17%0.35%-0.18%5.03%13.87%19.72%21.73%
Operating Expenses160.02M137.12M132.79M136.82M140.45M222.67M175.85M146.47M143.03M157.53M137.6M138.58M129.33M110.17M121.95M115.47M123.28M119.78M111.01M121.34M
OpEx % of Revenue53.39%42.69%42.64%46.24%49.01%70.25%55.62%49.31%49.41%51.46%45.35%50.84%46.7%36.56%41.46%42.52%45.72%41.56%38.23%45.06%
Selling, General & Admin133.68M113.17M109.34M113.69M116.21M23.22M151.27M121.45M119.16M60.48M111.84M115.67M105.33M60.81M99.24M93.01M99.38M62.86M89.27M100.69M
SG&A % of Revenue44.6%35.24%35.11%38.43%40.56%7.32%47.84%40.89%41.17%19.76%36.86%42.43%38.03%20.18%33.74%34.25%36.85%21.81%30.74%37.39%
Research & Development26.34M23.95M23.45M23.13M24.24M26.03M24.58M25.02M23.87M23.99M25.76M22.92M24M23.42M22.71M22.46M23.9M23.15M21.74M20.65M
R&D % of Revenue8.79%7.46%7.53%7.82%8.46%8.21%7.77%8.42%8.25%7.84%8.49%8.41%8.67%7.77%7.72%8.27%8.86%8.03%7.49%7.67%
Other Operating Expenses000001000K0001000K0001000K0001000K00
Operating Income36.6M74.28M75.5M54.46M47.66M-23.86M38.71M47.42M39.99M45.82M67M38M55.86M94.53M80.21M67.89M56.32M80.57M90.45M62.35M
Operating Margin %12.21%23.13%24.24%18.41%16.63%-7.53%12.24%15.96%13.81%14.97%22.08%13.94%20.17%31.37%27.27%25%20.88%27.95%31.15%23.15%
Operating Income Growth %-23.2%411.3%95.04%14.85%19.18%-152.07%-42.23%24.77%-28.42%-51.52%-16.47%-44.02%-0.81%17.32%-11.32%8.89%-10.92%17.48%31.8%22.26%
EBITDA36.6M98.42M99.66M79.17M72M3.25M66.28M74.5M68.12M73.88M94.31M65.81M84.4M121.45M107.18M94.59M82.96M106.44M115.81M87.45M
EBITDA Margin %12.21%30.64%32%26.76%25.13%1.03%20.96%25.08%23.54%24.14%31.08%24.14%30.48%40.31%36.44%34.83%30.76%36.93%39.88%32.48%
EBITDA Growth %-49.16%2927.28%50.37%6.26%5.69%-95.6%-29.72%13.21%-19.29%-39.17%-12.01%-30.43%1.74%14.1%-7.45%8.17%-5.68%14.14%29.07%21.66%
D&A (Non-Cash Add-back)024.14M24.17M24.71M24.34M27.11M27.57M27.08M28.14M28.06M27.31M27.8M28.54M26.92M26.97M26.7M26.64M25.87M25.37M25.1M
EBIT067.76M74.45M52.95M50.92M-20.68M40.28M45.02M42.35M44.17M65.09M37.72M54.45M92.02M81.56M76.3M107.51M81.56M71.27M89.08M
Net Interest Income073K-2.24M-1.27M-1.96M-1.59M-981K-800K-1.25M-1.6M-3.29M-3.51M-4M-2.67M-393K-1.39M-3.36M-2.32M-2.33M-2.66M
Interest Income0-2.85M981K897K971K585K1.03M1.35M926K905K712K816K890K1.03M974K968K433K188K168K245K
Interest Expense0-2.92M3.22M2.17M2.93M2.18M2.01M2.15M2.18M2.51M4M4.33M4.89M3.7M1.37M2.36M3.79M2.5M2.49M2.9M
Other Income/Expense-1.91M-3.6M-4.27M-3.68M333K1M-434K-4.54M184K-4.16M-5.91M-4.62M-6.3M-6.21M-15K-1.46M47.4M-1.52M-21.68M23.83M
Pretax Income34.69M70.68M71.22M50.78M47.99M-22.86M38.27M42.88M40.17M41.66M61.08M33.39M49.56M88.32M80.2M66.43M103.72M79.05M68.77M86.18M
Pretax Margin %11.58%22.01%22.87%17.16%16.75%-7.21%12.11%14.43%13.88%13.61%20.13%12.25%17.9%29.31%27.26%24.46%38.46%27.43%23.68%32%
Income Tax6.4M16.06M20.18M12.78M9.81M-5.18M15.69M7.99M6.57M1.07M12.03M5.92M-1.44M12.83M9.98M16.42M13.98M17.14M8.63M14.12M
Effective Tax Rate %18.45%22.72%28.33%25.16%20.43%22.67%40.98%18.63%16.36%2.58%19.69%17.74%-2.9%14.53%12.44%24.72%13.48%21.68%12.55%16.38%
Net Income28.29M54.61M51.06M38.01M38.19M-17.68M22.59M34.89M33.6M40.59M49.06M27.46M50.99M75.48M70.22M50.01M89.56M61.52M60.74M80.17M
Net Margin %9.44%17%16.4%12.85%13.33%-5.58%7.14%11.75%11.61%13.26%16.17%10.08%18.41%25.05%23.87%18.41%33.21%21.35%20.92%29.77%
Net Income Growth %-25.91%408.92%126.04%8.94%13.65%-143.55%-53.96%27.03%-34.11%-46.23%-30.13%-45.08%-43.06%22.69%15.61%-37.63%28.64%311.26%32.67%73.26%
Net Income (Continuing)28.29M54.62M51.05M38.01M38.19M-17.68M22.59M34.89M33.6M40.59M49.06M27.46M50.99M75.48M70.22M50.01M89.73M61.91M60.14M72.06M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000-759K-1.05M-458K
EPS (Diluted)0.180.360.320.240.24-0.110.140.220.210.250.310.170.310.470.430.310.550.380.370.49
EPS Growth %-25%427.27%128.57%9.09%14.29%-144%-54.84%29.41%-32.26%-46.81%-27.91%-45.16%-43.64%23.68%16.22%-36.73%30.95%316.21%32.14%68.97%
EPS (Basic)0.180.350.330.240.25-0.110.140.220.210.260.310.170.320.480.450.320.570.390.390.51
Diluted Shares Outstanding157.93M157.01M156.94M157M156.36M155.76M158.94M160.63M161.12M160.65M160.5M160.06M161.94M161.92M161.62M161.75M162.17M163.59M163.88M164.83M
Basic Shares Outstanding156.8M155.96M155.89M155.84M155.46M154.91M157.37M158.43M158.53M157.87M157.31M157.53M158.13M157.5M157.31M157.01M156.93M156.81M157.09M157.24M
Dividend Payout Ratio-22.86%24.52%32.81%32.59%-55.69%36.5%37.76%31.11%25.64%45.73%24.82%16.69%17.92%25.12%14.01%20.38%20.71%15.69%